<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05024006</url>
  </required_header>
  <id_info>
    <org_study_id>SJREB-2020-20</org_study_id>
    <nct_id>NCT05024006</nct_id>
  </id_info>
  <brief_title>Public Health Emergency: SOLIDARITY TRIAL Philippines</brief_title>
  <official_title>An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care Philippines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of the Philippines</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of the Philippines</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an adaptive, randomized, open-label, controlled clinical trial utilizing an&#xD;
      adaptive design to compare effects of repurposed drugs with local standard of care alone on&#xD;
      major inpatient hospital outcomes. This is performed worldwide in collaboration with WHO.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 23, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Adaptive design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>Number of days from hospital admission up to 28 days post discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>Number of days from hospital admission to discharge up to 28 days post admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first receiving ventilation</measure>
    <time_frame>Number of days from hospital admission to day of receiving ventilatory support up to 28 days post admission</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">1314</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>LSoC</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Local Standard of Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rem+LSoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remdesivir with Local Standard of Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HCQ+LSoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydroxychloroquine with Local Standard of Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lopi/Rito+LSoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lopinavir/Ritonavir with Local Standard of Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lopi/Rito+IFN+LSoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lopinavir/Ritonavir and Interferon Beta 1a with Local Standard of Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IFN+LSoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interferon Beta 1a with Local Standard of Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACB+LSoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acalabrutinib with Local Standard of Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remdesivir</intervention_name>
    <description>Two intravenous loading doses, then daily infusion for 10 days</description>
    <arm_group_label>Rem+LSoC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>Two oral loading doses, then orally twice daily for 10 days</description>
    <arm_group_label>HCQ+LSoC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lopinavir / Ritonavir</intervention_name>
    <description>Orally twice daily for 14 days</description>
    <arm_group_label>Lopi/Rito+IFN+LSoC</arm_group_label>
    <arm_group_label>Lopi/Rito+LSoC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Interferon beta-1a</intervention_name>
    <description>Daily injection for 6 days</description>
    <arm_group_label>IFN+LSoC</arm_group_label>
    <arm_group_label>Lopi/Rito+IFN+LSoC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acalabrutinib</intervention_name>
    <description>Orally twice daily for 10 days</description>
    <arm_group_label>ACB+LSoC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consenting adults (age â‰¥18) hospitalised with the following criteria will be included&#xD;
             in the study:&#xD;
&#xD;
               1. Probable or confirmed COVID-19 regardless of severity, i.e., mild, moderate and&#xD;
                  severe cases&#xD;
&#xD;
               2. Not already receiving any of the study drugs&#xD;
&#xD;
               3. Without known allergy or contraindications to any of the study drugs (in the view&#xD;
                  of the physician responsible for their care), and&#xD;
&#xD;
               4. Without anticipated transfer within 72 hours to a non-study hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with contraindications to any of the study drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Baguio General Hospital</name>
      <address>
        <city>Baguio City</city>
        <state>Benguet</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cebu Doctor's University Hospital</name>
      <address>
        <city>Cebu City</city>
        <state>Cebu</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Perpetual Succor Hospital Cebu</name>
      <address>
        <city>Cebu City</city>
        <state>Cebu</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vicente Sotto Memorial Medical Center</name>
      <address>
        <city>Cebu City</city>
        <state>Cebu</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Philippines Medical Center</name>
      <address>
        <city>Davao City</city>
        <state>Davao</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Visayas University Medical Center</name>
      <address>
        <city>Iloilo City</city>
        <state>Iloilo</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Makati Medical Center</name>
      <address>
        <city>Makati City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese General Hospital</name>
      <address>
        <city>Manila</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manila Doctors Hospital</name>
      <address>
        <city>Manila</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ManilaMed - Medical Center Philippines</name>
      <address>
        <city>Manila</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Lazaro Hospital</name>
      <address>
        <city>Manila</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UP - Philippine General Hospital</name>
      <address>
        <city>Manila</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asian Hospital and Medical Center</name>
      <address>
        <city>Muntinlupa</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Institute for Tropical Medicine</name>
      <address>
        <city>Muntinlupa</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Juan de Dios Educational Foundation Inc - Hospital</name>
      <address>
        <city>Pasay</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Medical City</name>
      <address>
        <city>Pasig City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diliman Doctors Hospital</name>
      <address>
        <city>Quezon City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fe Del Mundo Medical Center</name>
      <address>
        <city>Quezon City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lung Center of the Philippines</name>
      <address>
        <city>Quezon City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Luke's Medical Center Quezon City</name>
      <address>
        <city>Quezon City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of the East Ramon Magsaysay Memorial Medical Center</name>
      <address>
        <city>Quezon City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>World Citi Medical Center</name>
      <address>
        <city>Quezon City</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Santos Medical Center</name>
      <address>
        <city>San Juan</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Luke's Medical Center Global</name>
      <address>
        <city>Taguig</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Batangas Medical Center</name>
      <address>
        <city>Batangas</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 21, 2021</study_first_submitted>
  <study_first_submitted_qc>August 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>August 21, 2021</last_update_submitted>
  <last_update_submitted_qc>August 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of the Philippines</investigator_affiliation>
    <investigator_full_name>Marissa Alejandria MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>COVID-19, Solidarity, Hydroxychloroquine, Lopinavir+Ritonavir, Interferon Beta 1a, Remdesivir</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Ritonavir</mesh_term>
    <mesh_term>Lopinavir</mesh_term>
    <mesh_term>Interferon-beta</mesh_term>
    <mesh_term>Interferon beta-1a</mesh_term>
    <mesh_term>Remdesivir</mesh_term>
    <mesh_term>Hydroxychloroquine</mesh_term>
    <mesh_term>Acalabrutinib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

